Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Camphene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (-)-Camphene SCHEMBL29406765 | 0.98 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL9803985 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL28998139 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL31057504 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL31305341 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL1244388 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL9616481 | 0.93 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL11793102 | 0.91 | CNR2 (0.40) | CNR2 | |
| Camphene SCHEMBL11793110 | 0.91 | CNR2 (0.40) | CNR2 | |
| Camphene SCHEMBL28662891 | 0.90 | CNR2 (0.40) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250185660-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING HERBIVOROUS PESTS AND REDUCING CROP DAMAGE USING PREDATORY INSECT SEMIOCHEMICALS | THE PENN STATE RESEARCH FOUNDATION | 2025-06-12 | — | — | US | claimed |
| CN-119823825-A | Myrtle essential oil and application of compound essential oil based on myrtle essential oil in pest control | 广东海洋大学 | 2025-04-15 | — | — | CN | claimed |
| US-20250113855-A1 | HYDRATING AND REHYDRATING COMPOSITOIN AND PRODUCT | IV THOUGHT PRODUCTS AND DESIGN CORP. | 2025-04-10 | — | — | US | claimed |
| WO-2024044693-A2 | METHODS AND COMPOSITIONS FOR DISRUPTING HERBIVOROUS PESTS AND REDUCING CROP DAMAGE USING PREDATORY INSECT SEMIOCHEMICALS | THE PENN STATE RESEARCH FOUNDATION (US) | 2024-02-29 | — | — | WO | claimed |
| WO-2022187973-A1 | DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH | ALLIED CORP. (CA) | 2022-09-15 | — | — | WO | claimed |
| CN-109260440-A | A kind of bathing fumigation bathing lotion and preparation method | 菩艾堂（湖北）蕲艾科技有限公司 | 2019-01-25 | — | — | CN | claimed |
| CN-106146960-A | A kind of preparation method of vapor-permeable type antibacterial sponge | 湖北孺子牛鞋业集团有限公司 | 2016-11-23 | — | — | CN | claimed |
| EP-0305807-B1 | Traction drive fluid | IDEMITSU KOSAN CO (JP) | 1993-12-22 | — | — | EP | claimed |
| US-4975215-A | Hydrogenated dimers, trimers or polymers of terpenes; heat and cold resistance; low viscosity | IDEMITSU KOSAN CO., LTD. (JP) | 1990-12-04 | — | — | US | claimed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4665318-A2 | THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS | Native Code Bio, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| CN-1024464-C | Method for preparing isoborneol by catalyzing camphene hydration with resin | GUANGZHOU CHEM INST (CN) | 1994-05-11 | — | — | CN | disclosed |
| EP-0305807-B1 | Traction drive fluid | IDEMITSU KOSAN CO (JP) | 1993-12-22 | — | — | EP | disclosed |
| CN-1065451-A | The method of preparation of high purity camphor from dehydrogenated and impuritier removal iso-borneo camphor | GUANGZHOU CHEMISTRY INST CAS (CN) | 1992-10-21 | — | — | CN | disclosed |
| CN-1049842-A | Method for preparing isoborneol by catalyzing camphene hydration with resin | GUANGZHOU CHEM INST (CN) | 1991-03-13 | — | — | CN | disclosed |
| US-4975215-A | Hydrogenated dimers, trimers or polymers of terpenes; heat and cold resistance; low viscosity | IDEMITSU KOSAN CO., LTD. (JP) | 1990-12-04 | — | — | US | disclosed |
| EP-0305807-A2 | Traction drive fluid | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | HMBS, SNCA, PYGB | CNR2 59/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | CNR2 2/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | CNR2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.